MARIA ABUAWAD OROPEZA: Open Payments
NPI 1346849569 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,105 in 68 payments from 16 companies in 2025. Trend: 2023 $2,648 · 2024 $2,001 · 2025 $2,105
Food & beverage: $2,024Education: $81
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 14 | $300 |
| GENZYME CORPORATION | 6 | $266 |
| UCB, Inc. | 5 | $214 |
| Organon LLC | 4 | $211 |
| ABBVIE INC. | 8 | $179 |
| Arcutis Biotherapeutics, Inc. | 2 | $169 |
| Amgen Inc. | 8 | $161 |
| Regeneron Healthcare Solutions, Inc. | 2 | $105 |
| PFIZER INC. | 1 | $105 |
| Janssen Biotech, Inc. | 5 | $104 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, VTAMA, SKYRIZI, Zoryve, OTEZLA, CIBINQO.
Industry payments across MD — which companies pay providers there.
